ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Nurse Practitioner, Family

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,502Medicare Part D Prescriptions Filled, Including Refills

Rank: 14 out of 459

$410K Total Retail Price of All Prescriptions

Rank: 36 out of 459

276 Patients Receiving at Least One Drug in Part D
64%Patients 65 Years and Older
39% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 276 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

25% of this provider’s 276 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

3% of this provider’s 5,614 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $65 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
HYDROCODONE-ACETAMINOPHEN 429 252 S3 1 2
SIMVASTATIN 345 258 2 1
LEVOTHYROXINE SODIUM 298 226 3 5
FUROSEMIDE 274 209 4 8
METFORMIN HCL 269 164 5 7
OMEPRAZOLE 212 92 6 3
LISINOPRIL 175 98 7 4
TRIAMTERENE-HCTZ 173 142 8 83
ATENOLOL 166 136 9 14
GABAPENTIN 149 99 10 10
GLIMEPIRIDE 148 83 11 39
METOPROLOL TARTRATE 135 89 12 11
AMLODIPINE BESYLATE 126 98 13 6
NEXIUM 111 63 14 16
POTASSIUM CHLORIDE 109 77 15 24
HYDROCHLOROTHIAZIDE 104 93 16 9
JANUVIA 102 71 17 69
LISINOPRIL-HYDROCHLOROTHIAZIDE 101 63 18 21
WARFARIN SODIUM 100 70 19 17
TRAMADOL HCL 92 36 20 13
MELOXICAM 88 80 21 34
AMITRIPTYLINE HCL 80 57 R 22 44
METOPROLOL SUCCINATE 79 45 23 27
ZOLPIDEM TARTRATE 77 43 24 19
GEMFIBROZIL 77 40 24 109
IBUPROFEN 71 42 26 65
LANTUS 71 21 26 81
CLOPIDOGREL 71 61 26 55
SERTRALINE HCL 65 32 29 20
LOSARTAN-HYDROCHLOROTHIAZIDE 65 28 29 49
FAMOTIDINE 64 25 31 116
CRESTOR 64 42 31 31
CYCLOBENZAPRINE HCL 62 13 R 33 41
PANTOPRAZOLE SODIUM 61 61 34 38
GLIPIZIDE ER 59 16 35 126
ALLOPURINOL 59 41 35 52
CYMBALTA 59 15 35 35
PRAVASTATIN SODIUM 58 55 38 12
CELEBREX 57 43 39 157
DILTIAZEM 24HR ER 57 57 39 186
CEPHALEXIN 55 43 41 136
LEVOFLOXACIN 54 32 42 145
LOSARTAN POTASSIUM 54 34 42 22
AZITHROMYCIN 54 41 42 25
RANITIDINE HCL 53 49 45 29
ISOSORBIDE MONONITRATE ER 53 47 45 75
CITALOPRAM HBR 52 39 47 18
DILTIAZEM 24HR CD 51 51 48 150
SPIRIVA 51 42 48 45
DIOVAN HCT 51 20 48 72
GLIPIZIDE 50 50 51 51
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 18, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.